1 Followers USX:AXSM - Axsome Therapeutics Inc

Axsome Therapeutics Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2013 Q4	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	0 -	0 -	8.82M -	25.67M 191.0%	50.04M 95.0%	144.61M 189.0%	182.49M 26.2%	223.44M 22.4%	270.6M 21.1%	251.02M -7.2%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	0 -	0 -	983K -	1.92M 95.7%	5.2M 170.1%	12.75M 145.4%	16.37M 28.4%	20.98M 28.1%	26.07M 24.3%	24.81M -4.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0 -	0 -	0 -	7.84M -	14.92M 90.4%	44.84M 200.5%	131.86M 194.1%	166.12M 26.0%	202.46M 21.9%	244.53M 20.8%	226.22M -7.5%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	119.79M 11.4%	124.71M 4.1%	135.15M 8.4%	153.16M 13.3%	179.06M 16.9%	226.54M 26.5%	289.36M 27.7%	346.2M 19.6%	407M 17.6%	453.51M 11.4%	496.08M 9.4%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	119.79M 11.4%	124.71M 4.1%	135.15M 8.4%	152.18M 12.6%	176.15M 15.8%	221.34M 25.7%	276.61M 25.0%	329.83M 19.2%	386.02M 17.0%	427.44M 10.7%	471.27M 10.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-119.79M -	-124.71M -	-135.15M -	-144.35M -	-153.39M -	-176.5M -	-144.75M -	-163.71M -	-183.56M -	-182.91M -	-245.06M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-125.59M -	-130.4M -	-140.78M -	-149.93M -	-159.87M -	-187.13M -	-158.72M -	-184.45M -	-201.83M -	-239.24M -	-296.38M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-125.59M -	-130.4M -	-140.78M -	-149.93M -	-159.87M -	-187.13M -	-158.72M -	-184.45M -	-201.83M -	-239.24M -	-296.38M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-3.36 -	-3.47 -	-3.72 -	-3.92 -	-4.07 -	-4.6 -	-3.83 -	-4.31 -	-4.57 -	-5.27 -	-6.45 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-3.36 -	-3.47 -	-3.72 -	-3.92 -	-4.07 -	-4.6 -	-3.83 -	-4.31 -	-4.57 -	-5.27 -	-6.45 -